Register Now: IKRIS Breast Cancer Awareness Run 2022

Tag Archives: Acid sphingomyelinase deficiency

FDA Approves Xenpozyme: The First Disease-specific Medication for Acid Sphingomyelinase Deficiency (ASMD)

On August 31, 2022, the U.S. FDA approved Xenpozyme (Olipudase alfa) for intravenous infusion in pediatric and adult patients with […]

ikrisuser
September 8, 2022